Intratumoral Electroporation of Plasmid Encoded IL12 and Membrane-Anchored Anti-CD3 Increases Systemic Tumor Immunity
Overview
Authors
Affiliations
Implications: This DNA-encodable polyclonal T-cell stimulator (membrane-anchored anti-CD3 plasmid) may represent a key addition to intratumoral IL12 therapies in the clinic.
Therapeutic Immunomodulation of Tumor-Lymphatic Crosstalk via Intratumoral Immunotherapy.
Lucas S, Thomas S Mol Pharm. 2024; 21(12):5929-5943.
PMID: 39478434 PMC: 11615947. DOI: 10.1021/acs.molpharmaceut.4c00692.
Delivery of DNA-Based Therapeutics for Treatment of Chronic Diseases.
Sussman C, Liberatore R, Drozdz M Pharmaceutics. 2024; 16(4).
PMID: 38675196 PMC: 11053842. DOI: 10.3390/pharmaceutics16040535.
Campana L, Daud A, Lancellotti F, Arroyo J, Davalos R, Di Prata C Cancers (Basel). 2023; 15(13).
PMID: 37444450 PMC: 10340685. DOI: 10.3390/cancers15133340.
Aggarwal C, Saba N, Algazi A, Sukari A, Seiwert T, Haigentz M Clin Cancer Res. 2022; 29(3):560-570.
PMID: 36455147 PMC: 9890138. DOI: 10.1158/1078-0432.CCR-22-1987.
Antitumor Activities of Interleukin-12 in Melanoma.
Gao W, Pan J, Pan J Cancers (Basel). 2022; 14(22).
PMID: 36428682 PMC: 9688694. DOI: 10.3390/cancers14225592.